Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Invested Capital (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Invested Capital for 17 consecutive years, with $547.1 million as the latest value for Q1 2026.

  • Quarterly Invested Capital fell 1.44% to $547.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $547.1 million through Jan 2026, down 1.44% year-over-year, with the annual reading at $547.1 million for FY2026, 1.44% down from the prior year.
  • Invested Capital for Q1 2026 was $547.1 million at Usana Health Sciences, up from $528.1 million in the prior quarter.
  • The five-year high for Invested Capital was $555.1 million in Q4 2024, with the low at $395.1 million in Q1 2022.
  • Average Invested Capital over 5 years is $482.2 million, with a median of $498.0 million recorded in 2023.
  • The sharpest move saw Invested Capital fell 10.53% in 2022, then grew 16.14% in 2023.
  • Over 5 years, Invested Capital stood at $434.5 million in 2022, then rose by 14.62% to $498.0 million in 2023, then grew by 11.47% to $555.1 million in 2024, then decreased by 4.87% to $528.1 million in 2025, then rose by 3.6% to $547.1 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods came in at $547.1 million, $528.1 million, and $531.1 million for Q1 2026, Q3 2025, and Q2 2025 respectively.